FDA product code QQU: Digital Therapy Device For Amblyopia

QQU is the FDA product code for digital therapy device for amblyopia. It is a Class II device, regulated under 21 CFR 886.5500 and reviewed by the Ophthalmic panel. FDA has cleared 4 510(k) submissions under QQU, 4 in the last five years, from 2 different applicants. The average 510(k) review took 167 days (median 144); 190 days on average over the last three years. 1 De Novo request was granted under it.

Definition

A digital therapy device for amblyopia is a device that incorporates dichoptic presentations on visual displays through therapeutic algorithms to treat amblyopia or to improve visual acuity of patients with amblyopia.

Classification

FieldValue
Device nameDigital Therapy Device For Amblyopia
Device classClass II
Regulation21 CFR 886.5500
Review panelOP — Ophthalmic
Medical specialtyOphthalmic
Premarket route510(k)

510(k) clearances per year for QQU

YearClearancesAvg. review days
20222144
20241261
20251118

Compare with all 510(k) review times · Search every QQU clearance

Top QQU applicants

ApplicantClearancesLatest
Luminopia, Inc.32025-04-09
Novasight , Ltd.12022-09-29

Most recent QQU clearances

510(k)ApplicantDeviceDecision dateReview days
K243819Luminopia, Inc.Luminopia2025-04-09118
K233720Luminopia, Inc.Luminopia2024-08-08261
K221659Luminopia, Inc.Luminopia One2022-11-04149
K221375Novasight , Ltd.CureSight-CS1002022-09-29140

Recalls for QQU devices

FDA recall records list no recalls for product code QQU.

Frequently asked questions

What is FDA product code QQU?

QQU is the FDA product code for digital therapy device for amblyopia. It is a Class II device, regulated under 21 CFR 886.5500 and reviewed by the Ophthalmic panel.

What device class is QQU?

Class II, regulation 21 CFR 886.5500. Typical premarket route: 510(k).

How long does a 510(k) take for product code QQU?

Across 4 cleared submissions the average was 167 days from receipt to decision (median 144).

Which companies have the most QQU clearances?

Luminopia, Inc. (3); Novasight , Ltd. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Ophthalmic product codes · FDA product code lookup · 510(k) database search · 510(k) review times